News
Xos, Inc. (XOS) Q3 Earnings Top Estimates
Xos, Inc. (XOS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of a loss of $0.73 per share. This compares to a loss of $1.32 per share a year ago. These
Beazer Homes (BZH) Q4 Earnings and Revenues Top Estimates
Beazer Homes (BZH) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $1.69 per share a year ago. These figures
Shimmick Corporation (SHIM) Reports Q3 Loss, Tops Revenue Estimates
Shimmick Corporation (SHIM) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.72 per share a year ago. These
Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates
Profound Medical (PROF) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.38 per share a year ago. These figures
Fluent (FLNT) Reports Q3 Loss, Misses Revenue Estimates
Fluent (FLNT) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.22 per share a year ago. These figures are
Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates
Aytu BioPharma Inc. (AYTU) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.2 per share a year ago. These
TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.96 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.4 per share a year ago
TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates
TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.42 per share a year ago. These figures
Luminar Technologies, Inc. (LAZR) Reports Q3 Loss, Beats Revenue Estimates
Luminar Technologies, Inc. (LAZR) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $1.05. This compares to a loss of $2.4 per share a year ago
Applied Materials (AMAT) Tops Q4 Earnings and Revenue Estimates
Applied Materials (AMAT) came out with quarterly earnings of $2.17 per share, beating the Zacks Consensus Estimate of $2.11 per share. This compares to earnings of $2.32 per share a year ago. These
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates
Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.32 per share a year ago. These
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates
Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.21 per share a year ago
Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates
Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.55 per share a year ago. These
Clipper Realty Inc. (CLPR) Q3 FFO Beat Estimates
Clipper Realty Inc. (CLPR) came out with quarterly funds from operations (FFO) of $0.13 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to FFO of $0.18 per share a
Disney’s 2026 Outlook Brightens Under Iger's Magic Touch
It’s taken time, but Bob Iger’s magic is working on The Walt Disney Company (NYSE: DIS), setting its investors up for robust share price gains in 2026. While the Q4 results were mixed, providing
Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher
Thursday, November 13, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA
AI Frenzy: Everybody Wants NVIDIA's Magical GPUs
The AI frenzy continues to dominate headlines, with poster child NVIDIA NVDA at the forefront of conversations. The company largely remains the go-to pick concerning AI from a demand standpoint
Forget Netflix—Paramount Skydance’s $3B Plan Is Turning Heads on Wall Street
In the crowded and competitive streaming landscape, a decisive market reaction can speak volumes. Following its first post-merger earnings report, shares of Paramount Skydance (NASDAQ: PSKY)
Airline Stocks to Watch as the Government Shutdown Ends
Airline stocks have been pleasantly resilient, with many seeing a nice spike as the 43-day and longest government shutdown in American history comes to an end.
This makes it a worthy topic of which
Do Options Traders Know Something About BRLT Stock We Don't?
Investors in Brilliant Earth Group, Inc. BRLT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $7.5 Call had some of the
Is the Options Market Predicting a Spike in BWIN Stock?
Investors in The Baldwin Insurance Group, Inc. BWIN need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $22.5 Callhad some of the
3 Hidden Gem AI Stocks to Buy Now
- (0:30) - Finding Hidden AI Stocks That You Should Consider For Your Portfolio
- (9:00) - How To Screen For Zacks #1 Rank Stocks
- (16:05) - Tracey’s Top Stock Picks For Your Watchlist
- (41:10) -
Spectrum Brands' Q4 Earnings Beat Estimates, Organic Sales Dip 6.6% Y/Y
Spectrum Brands Holdings Inc. SPB has reported mixed fourth-quarter fiscal 2025 results, wherein the top line missed the Zacks Consensus Estimate while the bottom line beat. Earnings improved year
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
Becton, Dickinson and Company BDX, popularly known as BD, expanded its PureWick portfolio with a new first-of-its-kind Portable Collection System designed to help wheelchair users manage urinary
Is ARM Stock Still a Smart Bet After Its Record Q2 Results?
Investors were waiting to see how the market would respond to Arm Holdings plc’s ARM impressive second-quarter fiscal 2026 earnings and the reaction has been cautious.
Despite reporting another


